FDA approves new ADHD drug for children, the first in more than a decade By Linda A. Johnson article UNITED STATES - NOVEMBER 9 - The outside of the Food and Drug Administration headquarters is seen in White Oak, Md., on Monday, November 9, 2015. The FDA is a federal agency of the United States Department of Health and Human Services and has been in Expand U.S. regulators have approved the first new drug in over a decade for children with ADHD, which causes inattention, hyperactivity and impulsivity. The Food and Drug Administration late Friday OK’d Qelbree for treating attention deficit hyperactivity disorder in children ages 6 to 17. It comes as a capsule that’s taken daily.